TETRAPHASE PHARMACEUTICALS INC Long-Term Debt, Maturity, Year Four
TETRAPHASE PHARMACEUTICALS INC had Long-Term Debt, Maturity, Year Four of $9.23 million as of 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2019-08-08
- 2019-06-30: Long-Term Debt, Maturity, Year Four $9.23M.
- 2019-03-31: Long-Term Debt, Maturity, Year Four $9.23M.
- 2018-12-31: Long-Term Debt, Maturity, Year Four $9.23M.
- 2013-09-30: Long-Term Debt, Maturity, Year Four $1.13M.
| Period end | Long-Term Debt, Maturity, Year Four |
|---|---|
| 2019-06-30 | $9.23M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $9.23M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $9.23M 10-K · filed 2019-03-15 |
| 2013-09-30 | $1.13M 10-Q · filed 2013-11-14 |